Equity Markets — Page 5
Page 5 of the Equity Markets archive on FinancialMarkets.com.
Latest articles
- Washington Opened a Farm-Equipment Inquiry and Deere Fell $26 in Nine Minutes. CNH and AGCO Had Already Dropped Before It.
- In July, Hess Midstream Targeted 5% Payout Growth Through 2028. After the Chevron Deal, Growth Stops in December and the Stock Fell 14%.
- Worthington Steel’s Sales Triple as Operating Margins Narrow
- Neogen Rebounds After Earnings Beat and Higher Guidance
- Penguin Solutions Raises Outlook as Memory Drives Revenue Growth
- Constellation Brands Beats Estimates as Beer Demand Softens
- Marvell Targets $80 Billion in Revenue as Connectivity Peers Outperform
- Hess Midstream’s Cash Flow Per Unit Stays Flat After Chevron Deal
- S&P 500 Hits a Record as Market Breadth Remains Narrow
- Skydance Shares Fall After Closing $110 Billion Warner Bros. Deal
- Marvell Sets $70 Billion to $90 Billion Revenue Target for Fiscal 2031
- Google Nuclear Deal Sends Constellation and Power Stocks Higher
- Washington Offers Vistra Up to $4.2 Billion to Wring More Power From Old Reactors
- Half Stock, Half Convertible: How Vaxcyte Plans to Pay for a Vaccine Rollout Before Regulators Rule
- Lennar Slides 9% in Two Days as Investors Weigh a Short Seller's Millrose Claims
- Chevron Is Putting Its Low-Carbon Chief in Charge of the Cash and Its Finance Chief in Charge of the Oil
- The Nasdaq Hit a Record With the 10-Year Yield at a 24-Year High. New Lows Beat New Highs for a 26th Day.
- An Eight-Word Post From Musk Split Intel and TSMC
- Vaxcyte Cleared 37 of 39 Head-to-Head Strain Tests and Kept About Half of a $4.9 Billion Opening Gain
- PTC Holders Got a 42% Premium. The Market Is Charging Almost Nothing to Wait Two Years for It.
- AI Leaders Carry Another Global Session as the Rest of the Market Lags
- Vaxcyte's 31-Strain Vaccine Faces Its Head-to-Head Test Against Pfizer and Merck
- Qualcomm Gets a Huawei Royalty Stream Back, and Pays for Some Patents Along the Way
- Wall Street Paid Up for PTC. Paris Charged Schneider for It.